Locations:
Search IconSearch
November 18, 2020/Neurosciences/Podcast

Virtual Neurological Care: From Telestroke to Today (Podcast)

The latest developments in telemedicine for subspecialty neuro care

The COVID-19 pandemic has fueled not only a surge in virtual outpatient visits, but also an increase in telemedicine for subspecialty neurological care. Consider the experience of Cleveland Clinic, which started a telestroke program about 10 years ago to bring acute stroke assessment to community hospitals that didn’t have consistent stroke coverage. Now Cleveland Clinic has expanded its use of telemedicine to neuro ICUs, neurophysiologic monitoring and more, notes stroke neurologist Zeshaun Khawaja, MD, MBA, who currently leads Cleveland Clinic’s telestroke program.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Dr. Khawaja shares the latest developments in virtual neurological care in the newest episode of Cleveland Clinic’s Neuro Pathways podcast. Among the topics discussed:

  • What’s been learned from the telestroke program and how it has evolved in the past decade
  • How telemedicine is increasing access, improving care and reducing neurologist burnout
  • The next neurological subspecialties positioned to benefit from telemedicine
  • Tips for neurologists preparing to offer virtual visits or expand telemedicine beyond outpatient settings

Click the player above to listen to the podcast now, or read on for a short edited excerpt. Check out more Neuro Pathways episodes at clevelandclinic.org/neuropodcast or wherever you get your podcasts.

Excerpt from the podcast

Podcast host Glen Stevens, DO, PhD: Our colleagues in neurophysiology have also started to adapt this technology. Tell me about that.

Dr. Khawaja: We’ve learned that virtual health is not just a face-to-face encounter. Imad Najm, MD, [Director of Cleveland Clinic’s Shor Epilepsy Center] and his epileptologist partners are really experts in this. They’ve been able to leverage their experience to offer a host of services, including direct patient evaluations — in both inpatient and outpatient settings — and patient management conferences. These are in-depth conferences that help determine if patients are candidates for highly specialized epilepsy surgery. The best thing is that they don’t require any patient travel, and don’t even require that patients come to Cleveland to have the surgery. Patients can benefit from these conferences and have surgery in their home community.

Advertisement

Dr. Najm’s group also has been able to create, run and manage entire epilepsy monitoring unit programs virtually, everything from design to training the technicians.

Dr. Stevens: What other areas of neurologic care do you see benefiting from telemedicine?

Dr. Khawaja: There’s so much potential. We’ve just scratched the surface with telestroke, with teleneurology. Now we’re seeing teleneurophysiology doing great things.

There are so many patients across our nation who don’t have access to specialists. Sometimes they’re forced to travel long distances just to see someone. This is not only disruptive to their normal routines, but it can be very costly — not just money spent on travel, but income lost due to being away from work.

As we continue to gain experience and experiment within virtual health, I’m really eager to see what comes next, particularly in the management of movement disorders, such as Parkinson’s disease. Medical management of these patients is very, very complex. When they’re hospitalized, sometimes their medications need to be changed. And then as they transition to the outpatient space, all of this can severely affect progression of the disease.

We’ve seen that one of the most common uses of telemedicine in the neuro space is the management of movement disorders, particularly Parkinson’s patients. So I’m really eager to see what we can do there. I’m also excited to see what we can do with telepsychiatry. I think there is significant potential.

Advertisement

Related Articles

Physical therapist helping patient walk with a powered exoskeleton and walker

Exoskeleton-Aided Physical Therapy Proves Feasible in MS

Study looked at mobility measures and safety

portrait of Dr. Kriti Bhayana against decorative background with podcast overlay
April 2, 2026/Neurosciences/Podcast

Practice Essentials for Pediatric and Perinatal Stroke (Podcast)

Types and presentation may differ from adults, but early recognition and intervention are just as key

Two-dimensional scatter plot of peak T1 versus T2 times from pre-extended lumbar drainage MRI

MR Fingerprinting Predicts Shunt Efficacy in NPH

Study tests potential for a more accurate treatment predictor

person going into a Gamma Knife machine for radiotherapy
March 25, 2026/Neurosciences/Brain Tumor

Predicting Response to Stereotactic Radiosurgery for Recurrent Glioblastoma

Study uses molecular and clinical stratification to help guide patient selection

illustration of human brain with rumor at top right
March 23, 2026/Neurosciences/Brain Tumor

Adding Eflornithine to Lomustine Extends Survival in Recurrent IDH-Mutant Grade 3 Astrocytoma

Phase 3 STELLAR trial underscores role of molecular stratification in glioma care

brain MRI taken from the back of the head
March 20, 2026/Neurosciences/Epilepsy

Unmasking the ‘Tethered’ Temporal Lobe: New MRI Metrics Improve Detection of Encephaloceles in Refractory Epilepsy

Early identification of temporal encephaloceles can improve surgical decision-making

brain scan with white lesion on right side

ARISE II Recommendations Chart a Course for Advancing Intracranial Hemorrhage Care

Academia, industry and government leaders develop consensus priorities

two brain scans side by side with a yellow circle on the left scan
March 13, 2026/Neurosciences/Epilepsy

SEEG Linked With More Complete Resection and Greater Seizure Freedom in MOGHE Subtype of Epilepsy

Insights from one of the first studies of invasive monitoring in the rare form of focal cortical dysplasia

Ad